Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Contact your GP or prescribing clinician if you experience: Persistent or worsening fatigue that interferes with daily activities and does not improve with adequate rest Significant breathlessness during normal activities or at rest Chest pain or palpitations these require same-day assessment Severe or persistent dizziness , particularly if associated with fainting episodes Marked pallor noticed by yourself or others Unusual food cravings (pica) or restless legs syndrome Difficulty concentrating or cognitive changes affecting work or daily function Heavy menstrual bleeding or any unexplained bleeding Signs of gastrointestinal bleeding black or tarry stools, persistent change in bowel habit, unintentional weight loss beyond expected with Wegovy, or difficulty swallowing Seek urgent medical attention (call 999 or attend A&E) if you develop: Severe chest pain or pressure Sudden severe breathlessness Loss of consciousness or near-fainting Rapid heart rate with chest discomfort These symptoms may indicate severe anaemia or other serious conditions requiring immediate assessment
Semaglutide GLP-1 addresses common weight loss challenges, such as overeating and habitual snacking, by regulating and curbing these tendencies, enabling individuals to achieve significant weight reduction and the full spectrum of the medications benefits
Liu R, Zhou L, Zhang Y, Sheng NJ, Wang ZK, Wu TZ, et al
Lv R, Zhao Y, Wang X, He Y, Dong N, Min X, Liu X, Yu Q, Yuan K, Yue H, Yin Q (2024) GLP-1 analogue liraglutide attenuates CIH-induced cognitive deficits by inhibiting oxidative stress, neuroinflammation, and apoptosis via the Nrf2/HO-1 and MAPK/NF-B signaling pathways
Constipation can build more slowly and persist as stomach and intestinal movement slows
This is the same delivery method used for semaglutide and tirzepatide
